Skip to main content

Advertisement

SpringerLink
Log in

Effect of CRP value on 18F–FDG PET vascular positivity in Takayasu arteritis: a systematic review and per-patient based meta-analysis

  • Review Article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study was to quantify the association between the CRP value and 18F–FDG PET vascular positivity in Takayasu arteritis (TAK) through a structured dedicated systematic review and meta-analysis.

Methods

From January 2000 to December 2016, the PubMed/MEDLINE database was searched for articles specifically dealing with the assessment of vascular inflammation using 18F–FDG PET and CRP biomarkers in TAK. Inclusion criteria for the qualitative analysis were (1) 18F–FDG PET used to assess the disease activity, (2) The use of the ACR criteria for the diagnosis of TAK, (3) No case mixed vasculitis (i.e., no giant cell arteritis), and (4) CRP concentration and clinical disease activity available. For the meta-analysis, PET-positive and PET-negative subgroups with the corresponding CRP concentrations were generated based on per patient data. The standard mean difference, which represents the effect of the CRP concentrations on the 18F–FDG PET vascular uptake, was computed for all studies, and then the results were pooled together.

Results

Among the 33 initial citations, nine complete articles including 210 patients fulfilled the inclusion criteria. Five studies found a significant correlation between the 18F–FDG PET and CRP concentration, one provided a trend towards association and three did not find any association between the two biomarkers. Six studies found a significant association between 18F–FDG PET and clinical disease activity, one found a trend towards association and the last two studies did not evaluate this correlation. The meta-analysis (121 patients) provided the following results: Standard Mean Deviation = 0.54 [0.15;0.92]; Chi2 = 3.35; I2 = 0%; Test for overall effect: Z = 2.70 (P = 0.007).

Conclusion

The CRP concentration only moderately reflects the 18F–FDG PET vascular positivity in TAK, suggesting dissociated information. Standardized longitudinal prospective studies are necessary to assess the value of 18F–FDG PET as an independent biomarker for subtle vascular wall inflammation detection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Maksimowicz-McKinnon K, Hoffman GS. Takayasu arteritis: what is the long-term prognosis? Rheum Dis Clin N Am. 2007;33:777–86. vi

    Article  Google Scholar 

  2. Borg FA, Dasgupta B. Treatment and outcomes of large vessel arteritis. Best Pract Res Clin Rheumatol. 2009;23:325–37.

    Article  PubMed  Google Scholar 

  3. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med. 1994;120:919–29.

    Article  CAS  PubMed  Google Scholar 

  4. Hoffman GS, Ahmed AE. Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from the international network for the study of the systemic Vasculitides (INSSYS). Int J Cardiol. 1998;66 Suppl 1:S191–4. discussion S195

    Article  CAS  PubMed  Google Scholar 

  5. Belhocine T, Blockmans D, Hustinx R, Vandevivere J, Mortelmans L. Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging. 2003;30:1305–13.

    Article  PubMed  Google Scholar 

  6. Walter MA, Melzer RA, Schindler C, Müller-Brand J, Tyndall A, Nitzsche EU. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging. 2005;32:674–81.

    Article  PubMed  Google Scholar 

  7. Direskeneli H, Aydin SZ, Merkel PA. Assessment of disease activity and progression in Takayasu’s arteritis. Clin Exp Rheumatol. 2011;29:S86–91.

    PubMed  PubMed Central  Google Scholar 

  8. Fuchs M, Briel M, Daikeler T, Walker UA, Rasch H, Berg S, et al. The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging. 2012;39:344–53.

    Article  PubMed  Google Scholar 

  9. Soussan M, Nicolas P, Schramm C, Katsahian S, Pop G, Fain O, et al. Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis. Medicine (Baltimore). 2015;94:e622.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, et al. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med. 2013;54:647–58.

    Article  PubMed  Google Scholar 

  11. Grayson PC, Tomasson G, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, et al. Association of vascular physical examination findings and arteriographic lesions in large vessel vasculitis. J Rheumatol. 2012;39:303–9.

    Article  PubMed  Google Scholar 

  12. Webb M, Chambers A, Al-Nahhas A, Mason JC, Maudlin L, Rahman L, et al. The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging. 2004;31:627–34.

    Article  PubMed  Google Scholar 

  13. Andrews J, Al-Nahhas A, Pennell DJ, Hossain MS, Davies KA, Haskard DO, et al. Non-invasive imaging in the diagnosis and management of Takayasu’s arteritis. Ann Rheum Dis. 2004;63:995–1000.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kobayashi Y, Ishii K, Oda K, Nariai T, Tanaka Y, Ishiwata K, et al. Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med. 2005;46:917–22.

    PubMed  Google Scholar 

  15. Lee SG, Ryu J-S, Kim HO, Oh JS, Kim YG, Lee C-K, et al. Evaluation of disease activity using F-18 FDG PET-CT in patients with Takayasu arteritis. Clin Nucl Med. 2009;34:749–52.

    Article  PubMed  Google Scholar 

  16. Arnaud L, Haroche J, Malek Z, Archambaud F, Gambotti L, Grimon G, et al. Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis? Arthritis Rheum. 2009;60:1193–200.

    Article  PubMed  Google Scholar 

  17. Tezuka D, Haraguchi G, Ishihara T, Ohigashi H, Inagaki H, Suzuki J, et al. Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. JACC Cardiovasc Imaging. 2012;5:422–9.

    Article  PubMed  Google Scholar 

  18. Lee K-H, Cho A, Choi Y-J, Lee S-W, Ha Y-J, Jung S-J, et al. The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with takayasu arteritis. Arthritis Rheum. 2012;64:866–75.

    Article  PubMed  Google Scholar 

  19. Karapolat I, Kalfa M, Keser G, Yalçin M, Inal V, Kumanlioğlu K, et al. Comparison of F18-FDG PET/CT findings with current clinical disease status in patients with Takayasu’s arteritis. Clin Exp Rheumatol. 2013;31:S15–21.

    CAS  PubMed  Google Scholar 

  20. Alibaz-Oner F, Dede F, Ones T, Turoglu HT, Direskeneli H. Patients with Takayasu’s arteritis having persistent acute-phase response usually have an increased major vessel uptake by 18F-FDG-PET/CT. Mod Rheumatol. 2015;25:752–5.

    Article  PubMed  Google Scholar 

  21. Cohen J. Statistical power analysis for the Behavioral sciences. 2nd ed. Hillsdale: Erlbaum; 1988.

    Google Scholar 

  22. Takeshima N, Sozu T, Tajika A, Ogawa Y, Hayasaka Y, Furukawa TA. Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference? BMC Med Res Methodol. 2014;14:30.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Henes JC, Müller M, Krieger J, Balletshofer B, Pfannenberg AC, Kanz L, et al. [18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis. Clin Exp Rheumatol. 2008;26:S47–52.

    CAS  PubMed  Google Scholar 

  24. Santhosh S, Mittal BR, Gayana S, Bhattacharya A, Sharma A, Jain S. F-18 FDG PET/CT in the evaluation of Takayasu arteritis: an experience from the tropics. J Nucl Cardiol. 2014;21:993–1000.

    Article  PubMed  Google Scholar 

  25. Dhingra R, Talwar KK, Chopra P, Kumar R. An enzyme linked immunosorbent assay for detection of anti-aorta antibodies in Takayasu arteritis patients. Int J Cardiol. 1993;40:237–42.

    Article  CAS  PubMed  Google Scholar 

  26. Park MC, Lee SW, Park YB, Lee SK, Choi D, Shim WH. Post-interventional immunosuppressive treatment and vascular restenosis in Takayasu’s arteritis. Rheumatol (Oxford). 2006;45:600–5.

    Article  CAS  Google Scholar 

  27. Chauhan SK, Tripathy NK, Sinha N, Nityanand S. T-cell receptor repertoire of circulating gamma delta T-cells in Takayasu’s arteritis. Clin Immunol. 2006;118:243–9.

    Article  CAS  PubMed  Google Scholar 

  28. Park M-C, Park Y-B, Jung SY, Lee KH, Lee S-K. Anti-endothelial cell antibodies and antiphospholipid antibodies in Takayasu’s arteritis: correlations of their titers and isotype distributions with disease activity. Clin Exp Rheumatol. 2006;24:S10–6.

    PubMed  Google Scholar 

  29. Saadoun D, Garrido M, Comarmond C, Desbois AC, Domont F, Savey L, et al. Th1 and Th17 cytokines drive inflammation in Takayasu arteritis. Arthritis Rheumatol. 2015;67:1353–60.

    Article  CAS  PubMed  Google Scholar 

  30. Noris M, Daina E, Gamba S, Bonazzola S, Remuzzi G. Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions? Circulation. 1999;100:55–60.

    Article  CAS  PubMed  Google Scholar 

  31. Tripathi M, Chandrashekar N, Phom H, Gupta DK, Bajpai M, Bal C, et al. Evaluation of dilated upper renal tracts by technetium-99m ethylenedicysteine F+O diuresis renography in infants and children. Ann Nucl Med. 2004;18:681–7.

    Article  PubMed  Google Scholar 

  32. Mason JC. Takayasu arteritis--advances in diagnosis and management. Nat Rev Rheumatol. 2010;6:406–15.

    Article  PubMed  Google Scholar 

  33. Besson FL, Parienti J-J, Bienvenu B, Prior JO, Costo S, Bouvard G, et al. Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2011;38:1764–72.

    Article  PubMed  Google Scholar 

  34. Zhao S, Kuge Y, Kohanawa M, Takahashi T, Kawashima H, Temma T, et al. Extensive FDG uptake and its modification with corticosteroid in a granuloma rat model: an experimental study for differentiating granuloma from tumors. Eur J Nucl Med Mol Imaging. 2007;34:2096–105.

    Article  CAS  PubMed  Google Scholar 

  35. Stellingwerff MD, Brouwer E, Lensen K-JDF, Rutgers A, Arends S, van der Geest KSM, et al. Different scoring methods of FDG PET/CT in Giant cell Arteritis: need for standardization. Medicine (Baltimore). 2015;94:e1542.

    Article  Google Scholar 

  36. Incerti E, Tombetti E, Fallanca F, Baldissera EM, Alongi P, Tombolini E, et al. (18)F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis. Eur J Nucl Med Mol Imaging. 2017;44:1109–18.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biophysics and Nuclear Medicine, Bicêtre University Hospital, Assistance Publique-Hôpitaux de Paris, 94275, Le Kremlin-Bicêtre, France

    Léa Gomez, Philippe Chaumet-Riffaud, Emmanuel Durand & Florent L. Besson

  2. Department of Internal Medicine, Bicêtre University Hospital, Assistance Publique-Hôpitaux de Paris, 94275, Le Kremlin-Bicêtre, France

    Nicolas Noel, Olivier Lambotte & Cécile Goujard

  3. Université Paris Sud, Le Kremlin Bicêtre, France

    Nicolas Noel, Olivier Lambotte, Cécile Goujard, Emmanuel Durand & Florent L. Besson

  4. INSERM UMR 1184, Immunologie des Maladies Virales et Autoimmunes (IMVA), Université Paris Sud, Le Kremlin Bicêtre, France

    Nicolas Noel & Olivier Lambotte

  5. CEA, DSV/iMETI, Division of Immuno-Virology IDMIT, Paris, France

    Nicolas Noel, Olivier Lambotte & Cécile Goujard

  6. INSERM U1018, CESP, Le Kremlin Bicêtre, France

    Cécile Goujard

  7. IR4M - UMR8081, Université Paris Sud, Université Paris Saclay, CNRS, 91404, Orsay, France

    Emmanuel Durand & Florent L. Besson

Authors
  1. Léa Gomez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philippe Chaumet-Riffaud
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nicolas Noel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Olivier Lambotte
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Cécile Goujard
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Emmanuel Durand
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Florent L. Besson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Florent L. Besson.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gomez, L., Chaumet-Riffaud, P., Noel, N. et al. Effect of CRP value on 18F–FDG PET vascular positivity in Takayasu arteritis: a systematic review and per-patient based meta-analysis. Eur J Nucl Med Mol Imaging 45, 575–581 (2018). https://doi.org/10.1007/s00259-017-3798-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-017-3798-x

Keywords

Search

Navigation